These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9226734)

  • 21. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
    Liem-Moolenaar M; Gray FA; de Visser SJ; Franson KL; Schoemaker RC; Schmitt JA; Cohen AF; van Gerven JM
    J Psychopharmacol; 2010 Jan; 24(1):73-82. PubMed ID: 18755817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
    den Boon FS; Body S; Hampson CL; Bradshaw CM; Szabadi E; de Bruin N
    J Psychopharmacol; 2012 Sep; 26(9):1231-43. PubMed ID: 21969105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.
    McClelland GR; Cooper SM; Pilgrim AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):795-803. PubMed ID: 2288826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.
    Huang GB; Zhao T; Li CR; Sui ZY; Kang NI; Han EH; Chung YC
    Neurosci Lett; 2012 Oct; 528(2):131-6. PubMed ID: 22999925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.
    Park SW; Seo MK; Cho HY; Lee JG; Lee BJ; Seol W; Kim YH
    Neuropharmacology; 2011 Sep; 61(4):761-9. PubMed ID: 21663752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat.
    Cudennec A; Fage D; Bénavidès J; Scatton B
    Brain Res; 1997 Sep; 768(1-2):257-65. PubMed ID: 9369323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spotlight on amisulpride in schizophrenia.
    Curran MP; Perry CM
    CNS Drugs; 2002; 16(3):207-11. PubMed ID: 11888341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute phase of schizophrenia: impact of atypical antipsychotics.
    Azorin JM
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S5-9. PubMed ID: 11252521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs.
    Jóźwiak-Bębenista M; Jasińska-Stroschein M; Kowalczyk E
    Pharmacol Rep; 2018 Oct; 70(5):1032-1039. PubMed ID: 30144664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics.
    Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
    Eur J Pharmacol; 2014 Jul; 734():15-22. PubMed ID: 24726559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system effects of haloperidol on THC in healthy male volunteers.
    Liem-Moolenaar M; te Beek ET; de Kam ML; Franson KL; Kahn RS; Hijman R; Touw D; van Gerven JM
    J Psychopharmacol; 2010 Nov; 24(11):1697-708. PubMed ID: 20142302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.
    Möller HJ; Boyer P; Fleurot O; Rein W
    Psychopharmacology (Berl); 1997 Aug; 132(4):396-401. PubMed ID: 9298518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K; Plosker GL
    CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.
    Hou Y; Wu CF; Yang JY; Guo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1486-95. PubMed ID: 16842896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia.
    Mortimer AM; Joyce E; Balasubramaniam K; Choudhary PC; Saleem PT;
    Hum Psychopharmacol; 2007 Oct; 22(7):445-54. PubMed ID: 17691076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medico-economic assessment of neuroleptics in schizophrenia. Amisulpride versus haloperidol].
    Souêtre E; Martin P; Lecanu JP; Alexandre L; Lozet H; Gauthier JM; Camus C
    Encephale; 1992; 18(3):263-9. PubMed ID: 1363727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.